Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (11-20 of 281) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Rheumatology|August 6, 2013
Understanding itch in systemic sclerosis in order to improve patient quality of lifeTracy M Frech, Murray Baron
Arthritis and Rheumatism|October 2, 2007
Are the Short Form 36 physical and mental component summary scores useful measures in patients with systemic sclerosis? Comment on the article by Rannou et alMarie Hudson, Brett Thombs, Murray Baron
Journal of Cell Communication and Signaling|August 7, 2012
Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational researchMarie Hudson, Russell Steele, , et al.
The Journal of Rheumatology|March 3, 2011
Observational data to study medication outcomes in systemic sclerosisMarie Hudson, Murray Baron, , et al.
Journal of the American College of Nutrition|August 4, 2010
Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigmMurray Baron, Marie Hudson, Russell Steele, et al.
The Journal of Rheumatology|July 17, 2013
The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic reviewChayawee Muangchan, , Murray Baron, et al.
Arthritis Research & Therapy|April 14, 2026
Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung diseaseKathleen Morrisroe, Donald Tashkin, Murray Baron
Rheumatology International|September 25, 2009
What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG)Xiangning Fan, Janet Pope, , et al.
Rheumatology (Oxford, England)|December 17, 2021
Screening and management of subclinical interstitial lung disease in systemic sclerosis: an international surveySabrina Hoa, Murray Baron, Marie Hudson
Clinical Rheumatology|June 9, 2005
Shoulder hemarthrosis due to a bleeding pseudoaneurysmHarbhajan Kang, Murray Baron, Rafael Glikstein
Pageof 29

Showing results (11-20 of 281) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Rheumatology|August 6, 2013
Understanding itch in systemic sclerosis in order to improve patient quality of lifeTracy M Frech, Murray Baron
Arthritis and Rheumatism|October 2, 2007
Are the Short Form 36 physical and mental component summary scores useful measures in patients with systemic sclerosis? Comment on the article by Rannou et alMarie Hudson, Brett Thombs, Murray Baron
Journal of Cell Communication and Signaling|August 7, 2012
Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational researchMarie Hudson, Russell Steele, , et al.
The Journal of Rheumatology|March 3, 2011
Observational data to study medication outcomes in systemic sclerosisMarie Hudson, Murray Baron, , et al.
Journal of the American College of Nutrition|August 4, 2010
Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigmMurray Baron, Marie Hudson, Russell Steele, et al.
The Journal of Rheumatology|July 17, 2013
The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic reviewChayawee Muangchan, , Murray Baron, et al.
Arthritis Research & Therapy|April 14, 2026
Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung diseaseKathleen Morrisroe, Donald Tashkin, Murray Baron
Rheumatology International|September 25, 2009
What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG)Xiangning Fan, Janet Pope, , et al.
Rheumatology (Oxford, England)|December 17, 2021
Screening and management of subclinical interstitial lung disease in systemic sclerosis: an international surveySabrina Hoa, Murray Baron, Marie Hudson
Clinical Rheumatology|June 9, 2005
Shoulder hemarthrosis due to a bleeding pseudoaneurysmHarbhajan Kang, Murray Baron, Rafael Glikstein
Pageof 29